These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 28952322)
1. Coexistence of antiphospholipid antibodies and cephalalgia. Islam MA; Alam F; Gan SH; Cavestro C; Wong KK Cephalalgia; 2018 Mar; 38(3):568-580. PubMed ID: 28952322 [TBL] [Abstract][Full Text] [Related]
2. Comorbid association of antiphospholipid antibodies and migraine: A systematic review and meta-analysis. Islam MA; Alam F; Wong KK Autoimmun Rev; 2017 May; 16(5):512-522. PubMed ID: 28279839 [TBL] [Abstract][Full Text] [Related]
3. Anti-oxidized low-density-lipoprotein (OxLDL) antibodies in systemic lupus erythematosus with and without antiphospholipid syndrome. Hayem G; Nicaise-Roland P; Palazzo E; de Bandt M; Tubach F; Weber M; Meyer O Lupus; 2001; 10(5):346-51. PubMed ID: 11403265 [TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus. İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535 [TBL] [Abstract][Full Text] [Related]
5. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development]. Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013 [TBL] [Abstract][Full Text] [Related]
6. [Cardiological aspects of the antiphospholipid syndrome. Part I. Valvular lesions in the primary and secondary antiphospholipid syndrome and systemic lupus erythematosus]. Reshetniak TM; Kotel'nikova GP; Fomicheva OA; Kliukvina NG; Karpov IuA; Alexandrova EN; Alekberova ZS; Sergakova LM; Nasonova VA; Nasonov EL Kardiologiia; 2002; 42(8):38-43. PubMed ID: 12494093 [TBL] [Abstract][Full Text] [Related]
7. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies. Ofer-Shiber S; Molad Y Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus. Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721 [TBL] [Abstract][Full Text] [Related]
9. The Relationship Between Systemic Lupus Erythematosus Activity and Persistent Positive Antiphospholipid Antibodies. Sarabi ZS; Sahebari M; Rezaie AE; Norouzi MT; Hashemzadeh K; Mirfeizi Z Curr Rheumatol Rev; 2018; 14(2):145-152. PubMed ID: 27881058 [TBL] [Abstract][Full Text] [Related]
10. [Antiphospholipid syndrome and antiphospholipid antibodies as a risk factors of ischaemic heart disease and myocardial infarction in patients with systemic lupus erythematosus]. Ostanek L; Brzosko M; Fischer K; Płohska E Pol Arch Med Wewn; 2006 May; 115(5):407-13. PubMed ID: 17195352 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies and osteonecrosis in systemic lupus erythematosus: a meta-analysis. Qijiao W; Meng Z; Jianwen L; Shengli Z; Fei G; He L; Zhihan C Expert Rev Clin Immunol; 2021 Aug; 17(8):923-932. PubMed ID: 33956556 [No Abstract] [Full Text] [Related]
12. The association between systemic lupus erythematosus and valvular heart disease: an extensive data analysis. Watad A; Tiosano S; Grysman N; Comaneshter D; Cohen AD; Shoenfeld Y; Amital H Eur J Clin Invest; 2017 May; 47(5):366-371. PubMed ID: 28295225 [TBL] [Abstract][Full Text] [Related]
13. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE). Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D Lupus; 1997; 6(1):57-62. PubMed ID: 9116720 [TBL] [Abstract][Full Text] [Related]
14. Presence of Antiphospholipid Antibodies as a Risk Factor for Thrombotic Events in Patients with Connective Tissue Diseases and Idiopathic Thrombocytopenic Purpura. Habe K; Wada H; Matsumoto T; Ohishi K; Ikejiri M; Matsubara K; Morioka T; Kamimoto Y; Ikeda T; Katayama N; Mizutani H Intern Med; 2016; 55(6):589-95. PubMed ID: 26984073 [TBL] [Abstract][Full Text] [Related]
15. Risk of venous and arterial thrombosis according to type of antiphospholipid antibodies in adults without systemic lupus erythematosus: a systematic review and meta-analysis. Reynaud Q; Lega JC; Mismetti P; Chapelle C; Wahl D; Cathébras P; Laporte S Autoimmun Rev; 2014 Jun; 13(6):595-608. PubMed ID: 24418303 [TBL] [Abstract][Full Text] [Related]